Red Light Therapy

Red light therapy works by delivering specific wavelengths of red and near-infrared light directly to the cells, where they are absorbed by the mitochondria — the energy-producing structures inside every cell.

The primary mechanism is stimulation of the mitochondrial electron transport chain, which increases the production of ATP (adenosine triphosphate) — the body's cellular energy currency. With more available energy, cells are able to repair themselves faster, reduce inflammation more efficiently, and perform their biological functions at a higher level.

Mito Red Light devices emit clinically studied wavelengths of 660nm (red) and 850nm (near-infrared) to maximise this mitochondrial response. The result is improved cellular performance throughout the treated tissue — whether that is skin, muscle, joint, or bone.

Red light therapy uses two complementary types of light that work at different depths in the body.

Red light (620–700nm) is visible to the human eye and is most effective at the skin's surface. It stimulates collagen production, accelerates skin repair, reduces inflammation, and supports hair follicle health. Mito Red Light devices use 660nm as their primary red wavelength — the most clinically studied wavelength for surface-level benefits.

Near-infrared light (700–1100nm) is invisible to the human eye and penetrates significantly deeper — reaching muscle tissue, joints, tendons, and bone. It is the primary wavelength for pain relief, muscle recovery, and deeper systemic benefits. Mito Red Light devices use 850nm as their primary near-infrared wavelength.

All Mito Red Light panels emit both 660nm and 850nm simultaneously, delivering surface and deep-tissue benefits in a single session.

The right panel size depends on which areas of the body you want to treat and how efficiently you want to treat them.

For targeted treatment of the face, neck, or a specific joint, a compact panel such as the MitoPRO 300 or MitoPRO 500 delivers focused, high-intensity light to a smaller area and is ideal for desktop or close-proximity use.

For treating the full torso, back, or multiple body parts simultaneously, a full-body panel such as the MitoPRO 1500 or MitoMEGA dramatically reduces total session time. A larger panel covers more tissue per session — making it the better long-term investment for whole-body wellness.

As a general guideline: if your primary goal is skin health or facial rejuvenation, a compact panel is sufficient. If your goals include muscle recovery, pain relief, or systemic benefits, choose the largest panel within your budget.

The best red light therapy device depends on your primary goals, the area of the body you want to treat, and whether portability or maximum power is more important to you.

For most people, a full-sized red light therapy panel is the best investment. Panels deliver the highest irradiance, the widest coverage area, and the longest lifespan. Mito Red Light panels use dual-chip LEDs at 660nm and 850nm for simultaneous red and near-infrared delivery.

If you are new to red light therapy, the MitoPRO series is the recommended starting point — choose the largest size within your budget. If portability is a priority, Mito's flexible and handheld devices offer convenience without sacrificing clinical wavelengths. For specialised needs such as facial rejuvenation or hair regrowth, the MitoGLOW LED mask is engineered for those specific applications.

Not sure? Take our product quiz →

For most goals, daily or near-daily use of 10–20 minutes per treatment area is the evidence-based starting point. Red light therapy is cumulative — consistent use over weeks and months produces greater results than occasional high-dose sessions.

For skin health and anti-ageing benefits, most clinical protocols use 5 sessions per week at 10–15 minutes per session, at a distance of 6–12 inches from the panel. For muscle recovery and pain relief, sessions of 15–20 minutes immediately after exercise — or on rest days for chronic pain — are commonly used.

There is no established risk of overuse at standard irradiance levels, and Mito Red Light panels are designed for daily home use. New users should start at 3–5 sessions per week and increase frequency as tolerated.

The two most clinically validated wavelengths for red light therapy are 660nm (red) and 850nm (near-infrared). The majority of published photobiomodulation research uses wavelengths within the 630–680nm and 800–880nm ranges, with 660nm and 850nm being the most frequently studied specific wavelengths.

660nm targets surface tissue — it is absorbed most efficiently by skin cells, collagen structures, and hair follicles. 850nm penetrates deeper, reaching muscle, joint, and bone tissue.

Devices that emit both wavelengths simultaneously deliver surface and deep-tissue benefits in a single session, which is why dual-wavelength panels are the clinical standard. All Mito Red Light panels emit both 660nm and 850nm at independently optimised power levels.

Yes. Mito Red Light panels are FDA-registered as Class II medical devices. FDA registration means the device has been reviewed and listed under US regulatory requirements for light therapy devices.

FDA registration is distinct from FDA clearance — registration indicates the device is manufactured in compliance with FDA quality system regulations and has been formally listed with the FDA device database. Mito Red Light devices are produced in ISO-certified facilities and comply with applicable FDA requirements for light therapy devices.